Understanding how COVID-19 variants escape the immune system in Yucatan, Mexico
The impact of immune escape on the epidemiology and evolutionary dynamics of the COVID-19 pandemic in Yucatan, Mexico
This study looks at how COVID-19 variants change to avoid our immune system, especially in Yucatan, Mexico, and aims to help improve treatments and vaccines for everyone by understanding how these variants spread and behave.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Autonomous University of Yucatan NIH-funded |
| Lab location | 1 site (Merida, Mexico) |
| Project ID | NIH-10886115 on NIH RePORTER |
What this research studies
This research investigates the ways in which COVID-19 variants evolve to evade the immune response, particularly focusing on the epidemiology and transmission dynamics in Yucatan, Mexico. By analyzing genomic data and tracking the emergence of new variants, the study aims to identify patterns that could inform public health responses and vaccination strategies. Patients may benefit from improved understanding of variant behavior, which could lead to more effective treatments and preventive measures against COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Yucatan who have been infected with COVID-19 or are at risk of infection.
Not a fit: Patients who are not located in Yucatan or those who have not been affected by COVID-19 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better strategies for controlling COVID-19 and reducing its impact on public health.
How similar studies have performed: Previous research has shown success in understanding viral mutations and their impact on transmission, indicating that this approach has potential for meaningful insights.
Where this research is happening
Merida, Mexico
- Autonomous University of Yucatan — Merida, Mexico (Active)
Researchers
- Principal investigator: Ayora-Talavera, Guadalupe — Autonomous University of Yucatan
- Study coordinator: Ayora-Talavera, Guadalupe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.